-
[1]
J.N. Meng, V. Agrahari, I. Youm, J. Neuroimmune Pharmacol. 12 (2016) 84-98.
-
[2]
D. Peer, J.M. Karp, S. Hong, et al., Nat. Nanotechnol. 2 (2007) 751-760.
doi: 10.1038/nnano.2007.387
-
[3]
A.C. Anselmo, S. Mitragotri, Bioeng. Transl. Med. 1 (2016) 10-29.
doi: 10.1002/btm2.10003
-
[4]
C.I. Ochubiojo, M.E. Ibanga, S. Ifianyi, Nanotechnology in drug delivery, in: A. D. Sezer (Ed.), Recent Advances in Novel Drug Carrier Systems, Intech, Croatia, 2012.
-
[5]
V. Agrahari, V. Agrahari, Drug Discov. Today 23 (2018) 974-991.
doi: 10.1016/j.drudis.2018.01.047
-
[6]
V. Sainz, J. Conniot, A.I. Matos, et al., Biochem. Biophys. Res. Commun. 468 (2015) 504-510.
doi: 10.1016/j.bbrc.2015.08.023
-
[7]
S. Hassan, G. Prakash, A.B. Ozturk, et al., Nano Today 15 (2017) 91-106.
doi: 10.1016/j.nantod.2017.06.008
-
[8]
A. Pandit, D.I. Zeugolis, Nanomedicine: N. B. M. 11 (2016) 985-987.
doi: 10.2217/nnm.16.42
-
[9]
J.H. Xie, Y. Lu, B.Q. Yu, et al., Chin. Chem. Lett. 31 (2020) 1173-1177.
doi: 10.1016/j.cclet.2019.10.030
-
[10]
P. Srikanth, R. Narayana, S.R. Wasim, et al., Adv. Pharm. 3 (2013) 51-58.
-
[11]
Y. Wang, X.Q. Liang, R.S. Tong, et al., J. Biomed. Nanotechnol. 14 (2018) 1695-1704.
doi: 10.1166/jbn.2018.2626
-
[12]
Q.Q. Hu, L. Bai, Z.J. Zhu, Chin. Chem. Lett. 31 (2020) 915-918.
doi: 10.1016/j.cclet.2020.01.008
-
[13]
Y. Zhou, A.P. Fang, F.Z. Wang, et al., Chin. Chem. Lett. 31 (2020) 494-500.
doi: 10.1016/j.cclet.2019.04.048
-
[14]
X. Zhang, X. Ren, J. Tang, et al., Drug Deliv. 27 (2020) 825-835.
doi: 10.1080/10717544.2020.1770373
-
[15]
Y. Liang, Q.Q. Huo, W. Lu, et al., J. Biomed. Nanotechnol. 14 (2018) 1308-1316.
doi: 10.1166/jbn.2018.2585
-
[16]
Y. Qu, B. Chu, X. Wei, et al., J. Control. Release 296 (2019) 93-106.
doi: 10.1016/j.jconrel.2019.01.016
-
[17]
S.S. Kulthe, Y.M. Choudhari, N.N. Inamdar, et al., Des. Monomers Polym. 15 (2012) 465-521.
doi: 10.1080/1385772X.2012.688328
-
[18]
M. Talelli, M. Barz, C.J.F. Rijcken, et al., Nano Today 10 (2015) 93-117.
doi: 10.1016/j.nantod.2015.01.005
-
[19]
Y. Wang, X.X. Wang, J. Zhang, et al., Chin. Chem. Lett. 30 (2019) 885-888.
doi: 10.1016/j.cclet.2019.02.018
-
[20]
C.L. Zhu, S. Gong, J.S. Ding, et al., Acta Pharm. Sin. B 9 (2019) 107-117.
doi: 10.1016/j.apsb.2018.09.004
-
[21]
M. Cagel, F.C. Tesan, E. Bernabeu, et al., Eur. J. Pharm. Biopharm. 113 (2017) 211-228.
doi: 10.1016/j.ejpb.2016.12.019
-
[22]
Z. Zhang, Q. Sun, J. Zhong, et al., J. Biomed. Nanotechnol. 10 (2014) 216-226.
doi: 10.1166/jbn.2014.1729
-
[23]
K. Miyata, N. Nishiyama, K. Kataoka, Chem. Soc. Rev. 41 (2012) 2562-2574.
doi: 10.1039/C1CS15258K
-
[24]
N. Nishiyama, K. Kataoka, Adv. Polym. Sci. 193 (2015) 67-101.
-
[25]
X. Xu, W. Ho, X. Zhang, et al., Trends Mol. Med. 21 (2015) 223-232.
doi: 10.1016/j.molmed.2015.01.001
-
[26]
J.M. Caster, A.N. Patel, T. Zhang, A. Wang, Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 9 (2017) 1-18.
-
[27]
H. Havel, G. Finch, P. Strode, et al., AAPS J. 18 (2016) 1-6.
doi: 10.1208/s12248-015-9820-y
-
[28]
C.L. Ventola, Dermatol. Ther. 37 (2012) 631-639.
-
[29]
D. Bobo, K.J. Robinson, J. Islam, et al., Pharm. Res. 33 (2016) 2373-2387.
doi: 10.1007/s11095-016-1958-5
-
[30]
E.W. Party, C.F.R.F. Consultation, Stat. Med. 25 (2010) 1639-1645.
-
[31]
A.J.M. Ferreri, T. Calimeri, G.M. Conte, et al., Blood 134 (2019) 252-262.
-
[32]
C. Khanna, M. Rosenberg, D.M. Vail, J. Vet. Intern. Med. 29 (2015) 1006-1012.
doi: 10.1111/jvim.12596
-
[33]
Z.Y. Fan, C. Chen, X.Y. Pang, et al., PLoS One 10 (2015) e0120129.
doi: 10.1371/journal.pone.0120129
-
[34]
E. Miele, G.P. Spinelli, F. Tomao, Int. J. Nanomed. Nanosurg. 99 (2009) 99-105.
-
[35]
C.P. Yang, S. Horwitz, Int. J. Mol. Sci. 18 (2017) 1733.
doi: 10.3390/ijms18081733
-
[36]
S.C. Kim, D.W. Kim, Y.H. Shim, et al., J. Control. Release 72 (2001) 191-202.
doi: 10.1016/S0168-3659(01)00275-9
-
[37]
K.S. Lee, H.C. Chung, S.A. Im, et al., Breast Cancer Res. Tr. 108 (2007) 217-222.
-
[38]
D.W. Kim, S.Y. Kim, H.K. Kim, et al., Ann. Oncol. 18 (2007) 2009-2014.
doi: 10.1093/annonc/mdm374
-
[39]
T.Y. Kim, J.Y. Chung, Clin. Cancer Res. 10 (2004) 3708-3716.
doi: 10.1158/1078-0432.CCR-03-0655
-
[40]
H.S. Kim, J.Y. Lee, S.H. Lim, et al., J. Thorac. Oncol. 10 (2015) 762-768.
doi: 10.1097/JTO.0000000000000489
-
[41]
J.L. Lee, J.H. Ahn, S.H. Park, et al., Invest. New Drugs 30 (2012) 1984-1990.
doi: 10.1007/s10637-011-9757-7
-
[42]
M.W. Saif, N.A. Podoltsev, M.S. Rubin, et al., Cancer Invest. 28 (2010) 186-194.
-
[43]
S. Margaritora, A. Cesario, G. Cusumano, et al., Ann. Thorac. Surg. 89 (2010) 245-252.
doi: 10.1016/j.athoracsur.2009.08.074
-
[44]
G.L. Lemma, J.W. Lee, S.C. Aisner, et al., J. Clin. Oncol. 29 (2011) 2060-2065.
doi: 10.1200/JCO.2010.32.9607
-
[45]
H.K. Ahn, S.J. Sym, et al., Cancer Chemoth. Pharm. 74 (2014) 277-282.
doi: 10.1007/s00280-014-2498-5
-
[46]
ClinicalTrials. gov database, (2020). https://www.clinicaltrials.gov/ct2/results?cond=&term=GenexolPM&cntry=&state=&city=&dist=.
-
[47]
A. Saklani, S. Kutty, Drug Discov. Today 13 (2008) 161-171.
doi: 10.1016/j.drudis.2007.10.010
-
[48]
Y. Zhao, Z.F. Chang, R. Li, et al., Am. J. Transl. Res. 8 (2016) 5044-5051.
-
[49]
S. Jayashree, K. Nirekshana, G. Guha, D. Bhakta-Guha, Biomed. Pharmacother. 102 (2018) 894-911.
doi: 10.1016/j.biopha.2018.03.123
-
[50]
X. Zhang, H.M. Burt, D.V. Hoff, et al., Cancer Chemoth. Pharm. 40 (1997) 81-86.
doi: 10.1007/s002800050630
-
[51]
X. Yin, X. Cao, J. Li, et al., AAPS PharmSciTech 20 (2019) 629-638.
-
[52]
A. Ehrlich, S. Booher, Y. Becerra, et al., J. Am. Acad. Dermatol. 50 (2004) 533-540.
doi: 10.1016/j.jaad.2003.09.018
-
[53]
ClinicalTrials. gov database, (2020). https://www.clinicaltrials.gov/ct2/results?cond=&term=Paxceed&cntry=&state=&city=&dist=.
-
[54]
S. Emoto, H. Yamaguchi, J. Kishikawa, et al., Cancer Sci. 103 (2012) 1304-1310.
doi: 10.1111/j.1349-7006.2012.02274.x
-
[55]
I. Nakamura, E. Ichimura, R. Goda, et al., Int. J. Nanomedicine 12 (2017) 1293-1304.
doi: 10.2147/IJN.S114356
-
[56]
T. Hamaguchi, Y. Matsumura, M. Suzuki, et al., Brit. J. Cancer 92 (2005) 1240-1246.
doi: 10.1038/sj.bjc.6602479
-
[57]
T. Negishi, F. Koizumi, H. Uchino, et al., Brit. J. Cancer 95 (2006) 601-606.
doi: 10.1038/sj.bjc.6603311
-
[58]
K. Kato, K. Chin, T. Yoshikawa, et al., Invest. New Drugs 30 (2011) 1621-1627.
-
[59]
H. Mukai, K. Kato, T. Esaki, et al., Invest. New Drugs 34 (2016) 750-759.
doi: 10.1007/s10637-016-0381-4
-
[60]
T. Hamaguchi, K. Kato, H. Yasui, et al., Br. J. Cancer 97 (2007) 170-176.
doi: 10.1038/sj.bjc.6603855
-
[61]
Y. Fujiwara, H. Mukai, T. Saeki, et al., Brit. J. Cancer 120 (2019) 475-482.
doi: 10.1038/s41416-019-0391-z
-
[62]
ClinicalTrials. gov database, (2020). https://www.clinicaltrials.gov/ct2/results?cond=&term=NK105&cntry=&state=&city=&dist=.
-
[63]
H. von Euler, P. Rivera, H. Nyman, et al., Vet. Comp. Oncol. 11 (2013) 243-255.
doi: 10.1111/j.1476-5829.2011.00314.x
-
[64]
S. Hassan, S. Dhar, M. Sandström, et al., Cancer Chemoth. Pharm. 55 (2005) 47-54.
doi: 10.1007/s00280-004-0855-5
-
[65]
P. Rivera, N. Åkerlund-Denneberg, K. Bergvall, et al., J. Small Anim. Pract. 54 (2013) 20-27.
doi: 10.1111/j.1748-5827.2012.01304.x
-
[66]
D.M. Vail, H. von Euler, A.W. Rusk, et al., J. Vet. Intern. Med. 26 (2012) 598-607.
doi: 10.1111/j.1939-1676.2012.00897.x
-
[67]
B.G.H. Choudhury, M. Pandey, et al., Int. J. Pharm. 529 (2018) 506-522.
-
[68]
E.T. Oh, C.W. Kim, S.J. Kim, et al., Sci. Rep. -UK. 6 (2016) 1-37.
doi: 10.1038/s41598-016-0001-8
-
[69]
J.J.M.A. Hendrikx, J.S. Lagas, J.Y. Song, et al., Int. J. Cancer 138 (2016) 758-769.
doi: 10.1002/ijc.29812
-
[70]
S.Y. Song, K. Kim, S.Y. Jeong, Oncotarget 7 (2016) 77348-77357.
doi: 10.18632/oncotarget.12668
-
[71]
Y.M. Yin, F.D. Cui, C.F. Mu, et al., J. Control. Release 140 (2009) 86-94.
doi: 10.1016/j.jconrel.2009.08.015
-
[72]
G. Palma, C. Conte, A. Barbieri, et al., Int. J. Pharmaceut. 473 (2014) 55-63.
doi: 10.1016/j.ijpharm.2014.06.058
-
[73]
D.D. Von Hoff, M.M. Mita, R.K. Ramanathan, et al., Clin. Cancer Res. 22 (2016) 3157-3163.
doi: 10.1158/1078-0432.CCR-15-2548
-
[74]
J. Hrkach, D. Von Hoff, M.M. Ali, et al., Sci. Transl. Med. 4 (2012) 128-139.
-
[75]
K.A. Autio, R. Dreicer, J. Anderson, et al., JAMA Oncol. 4 (2018) 1344-1351.
doi: 10.1001/jamaoncol.2018.2168
-
[76]
H. Ledford, Biotechnology 533 (2016) 304-305.
-
[77]
ClinicalTrials. gov database, (2020). https://www.clinicaltrials.gov/ct2/results?cond=&term=BIND-014&cntry=&state=&city=&dist=.
-
[78]
S.W. Lee, M.H. Yun, S.W. Jeong, et al., J. Control. Release 155 (2011) 262-271.
doi: 10.1016/j.jconrel.2011.06.012
-
[79]
V.Q. Do, K.H. Park, J.M. Park, M.Y. Lee, Toxicol. Res. 35 (2019) 201-207.
doi: 10.5487/TR.2019.35.2.201
-
[80]
ClinicalTrials. gov database, (2020). https://www.clinicaltrials.gov/ct2/results?cond=&term=Nanoxel&cntry=&state=&city=&dist=.
-
[81]
ClinicalTrials. gov database, (2020). https://www.Clinicaltrialsregister.eu/ctr-search/search?query=Docecal.
-
[82]
X. Duan, C. He, S.J. Kron, W. Lin, Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 8 (2016) 776-791.
doi: 10.1002/wnan.1390
-
[83]
M. Yokoyama, T. Okano, Y. Sakurai, et al., J. Control. Release 39 (1996) 351-356.
doi: 10.1016/0168-3659(95)00165-4
-
[84]
Y. Mochida, H. Cabral, Y. Miura, et al., ACS Nano 8 (2014) 6724-6738.
doi: 10.1021/nn500498t
-
[85]
H. Uchino, Y. Matsumura, T. Negishi, et al., Brit. J. Cancer 93 (2005) 678-687.
doi: 10.1038/sj.bjc.6602772
-
[86]
N. Nishiyama, S. Okazaki, H. Cabral, et al., Cancer Res. 63 (2013) 8977-8983.
-
[87]
A. Varela-Moreira, Y. Shi, M.H.A.M. Fens, et al., Mater. Chem. Front. 1 (2017) 1485-1501.
doi: 10.1039/C6QM00289G
-
[88]
R. Plummer, R.H. Wilson, H. Calvert, et al., Brit. J. Cancer 104 (2011) 593-598.
doi: 10.1038/bjc.2011.6
-
[89]
T. Doi, T. Hamaguchi, K. Shitara, et al., Cancer Chemoth. Pharm. 79 (2017) 569-578.
doi: 10.1007/s00280-017-3254-4
-
[90]
V. Subbiah, J.E. Grilley-Olson, A.J. Combest, et al., Clin. Cancer Res. 24 (2018) 43-51.
doi: 10.1158/1078-0432.CCR-17-1114
-
[91]
ClinicalTrials. gov database, (2020). https://www.clinicaltrials.gov/ct2/results?cond=&term=NC6004&cntry=&state=&city=&dist=.
-
[92]
J. Cassidy, J.L. Misset, Semin. Oncol. 29 (2002) 11-20.
doi: 10.1053/sonc.2002.35524
-
[93]
H. Cabral, N. Nishiyama, S. Okazaki, et al., J. Control. Release 101 (2005) 223-232.
doi: 10.1016/j.jconrel.2004.08.022
-
[94]
R.H. Wilson, T. Lehky, R.R. Thomas, et al., J. Clin. Oncol. 20 (2002) 1767-1774.
doi: 10.1200/JCO.2002.07.056
-
[95]
L. Kelland, Nat. Rev. Cancer 7 (2007) 573-584.
doi: 10.1038/nrc2167
-
[96]
H. Cabral, K. Kataoka, J. Control. Release 121 (2007) 146-155.
doi: 10.1016/j.jconrel.2007.05.024
-
[97]
A.X. Zhu, L.S. Blaszkowsky, D.P. Ryan, et al., J. Clin. Oncol. 24 (2006) 1898-1903.
doi: 10.1200/JCO.2005.04.9130
-
[98]
H.J. Schmoll, T. Cartwright, J. Tabernero, et al., J. Clin. Oncol. 26 (2007) 102-109.
doi: 10.1200/JCO.2006.08.1075
-
[99]
J. Cassidy, S. Clarke, E. Díaz-Rubio, et al., J. Clin. Oncol. 26 (2008) 2006-2012.
doi: 10.1200/JCO.2007.14.9898
-
[100]
M. Ducreux, E. Mitry, M. Ould-Kaci, et al., Ann. Oncol. 15 (2004) 467-473.
doi: 10.1093/annonc/mdh098
-
[101]
C. Louvet, R. Labianca, P. Hammel, et al., J. Clin. Oncol. 23 (2005) 3509-3516.
doi: 10.1200/JCO.2005.06.023
-
[102]
C. Louvet, T. André, G. Lledo, et al., J. Clin. Oncol. 20 (2002) 1512-1518.
doi: 10.1200/JCO.2002.20.6.1512
-
[103]
S.R. Alberts, W.L. Horvath, W.C. Sternfeld, et al., J. Clin. Oncol. 23 (2005) 9243-9249.
doi: 10.1200/JCO.2005.07.740
-
[104]
N.I. Khushalani, C.G. Leichman, G. Proulx, et al., J. Clin. Oncol. 20 (2002) 2844-2850.
doi: 10.1200/JCO.2002.12.032
-
[105]
F. Lordick, B. Luber, S. Lorenzen, et al., Br. J. Cancer 102 (2010) 500-505.
doi: 10.1038/sj.bjc.6605521
-
[106]
ClinicalTrials. gov database, (2020). https://www.clinicaltrials.gov/ct2/results?cond=&term=NC4016&cntry=&state=&city=&dist=.
-
[107]
C. Annabelle, C. Nina, T. Nouritza, et al., Oncotarget 9 (2018) 14539-14551.
doi: 10.18632/oncotarget.24465
-
[108]
L.A.A. Gilliam, D.K. St. Clair, Antioxid. Redox Sign. 15 (2011) 2543-2563.
doi: 10.1089/ars.2011.3965
-
[109]
G. Stefania, D.A. Antonella, B. Liberato, et al., Oxid. Med. Cell. Longev. 75 (2018) 1-15.
-
[110]
C. Maximiliano, G. Estefania, B. Ezequiel, et al., Drug Discov. Today 22 (2017) 270-281.
doi: 10.1016/j.drudis.2016.11.005
-
[111]
F. Arcamone, G. Cassinelli, G. Fantini, et al., Biotechnol. Bioeng. 67 (2000) 704-713.
doi: 10.1002/(SICI)1097-0290(20000320)67:6<704::AID-BIT8>3.0.CO;2-L
-
[112]
M.A. Mitry, J.G. Edwards, Int. J. Cardiol. Heart Vasc. 10 (2015) 17-24.
-
[113]
D. Ren, M. Dalmau, A. Randall, et al., Adv. Funct. Mater. 22 (2012) 3170-3180.
doi: 10.1002/adfm.201200052
-
[114]
T. Nakanishi, S. Fukushima, K. Okamoto, et al., J. Control. Release 74 (2001) 295-302.
doi: 10.1016/S0168-3659(01)00341-8
-
[115]
Y. Matsumura, T. Hamaguchi, T. Ura, et al., Brit. J. Cancer 91 (2004) 1775-1781.
doi: 10.1038/sj.bjc.6602204
-
[116]
A.V. Kabanov, E.V. Batrakova, V.Y. Alakhov, Adv. Drug Deliv. Rev. 54 (2002) 759-779.
doi: 10.1016/S0169-409X(02)00047-9
-
[117]
S. Danson, D. Ferry, V. Alakhov, et al., Brit. J. Cancer 90 (2004) 2085-2091.
doi: 10.1038/sj.bjc.6601856
-
[118]
J.W. Valle, A. Armstrong, C. Newman, et al., Invest. New Drugs 29 (2010) 1029-1037.
-
[119]
A. Takahashi, Y. Yamamoto, M. Yasunaga, et al., Cancer Sci. 104 (2013) 920-925.
doi: 10.1111/cas.12153
-
[120]
Y. Matsumura, J. Clin. Oncol. 44 (2014) 515-525.
-
[121]
X.F. Wang, Z.F. Zhao, M.H. Chen, et al., Mol. Med. Rep. 12 (2015) 5917-5923.
doi: 10.3892/mmr.2015.4220
-
[122]
L.S. Tarpgaard, C. Qvortrup, S.B. Nygard, et al., BMC Cancer 16 (2016) 91.
doi: 10.1186/s12885-016-2124-5
-
[123]
H. Mukai, T. Kogawa, N. Matsubara, et al., Invest. New Drugs 35 (2017) 307-314.
doi: 10.1007/s10637-016-0422-z
-
[124]
M. Harada, I. Bobe, H. Saito, et al., Cancer Sci. 102 (2011) 192-199.
doi: 10.1111/j.1349-7006.2010.01745.x
-
[125]
ClinicalTrials. gov database, (2020). https://www.clinicaltrials.gov/ct2/results?cond=&term=+NC6300&cntry=&state=&city=&dist=.
-
[126]
C. Chaves, M. Taghi, M.C. Menet, et al., Pharmaceutics 12 (2020) 399-417.
doi: 10.3390/pharmaceutics12050399
-
[127]
M. Sumitomo, F. Koizumi, T. Asano, et al., Cancer Res. 68 (2008) 1631-1635.
doi: 10.1158/0008-5472.CAN-07-6532
-
[128]
Y. Matsumura, Adv. Drug Deliv. Rev. 63 (2011) 184-192.
doi: 10.1016/j.addr.2010.05.008
-
[129]
F.F. Han, C.L. Guo, D. Yu, et al., Cancer Chemoth. Pharm. 73 (2014) 779-788.
doi: 10.1007/s00280-014-2405-0
-
[130]
J. Gao, J. Zhou, Y. Li, et al., Medical Oncol. 30 (2013) 1-6.
-
[131]
J.A. Zhang, T. Xuan, M. Parmar, et al., Int. J. Pharm. 270 (2004) 93-107.
doi: 10.1016/j.ijpharm.2003.10.015
-
[132]
R. Zhang, R. Saito, Y. Mano, et al., Drug Deliv. 23 (2016) 2780-2786.
doi: 10.3109/10717544.2015.1081994
-
[133]
H.A. Burris, J.R. Infante, F.A. Greco, et al., Cancer Chemother. Pharmacol. 77 (2016) 1079-1086.
doi: 10.1007/s00280-016-2986-x
-
[134]
T. Hamaguchi, T. Doi, T. Eguchi-Nakajima, et al., Clin. Cancer Res. 16 (2010) 5058-5066.
doi: 10.1158/1078-0432.CCR-10-0387
-
[135]
T. Hamaguchi, A. Tsuji, K. Yamaguchi, et al., Cancer Chemother. Pharm. 82 (2018) 1021-1029.
doi: 10.1007/s00280-018-3693-6
-
[136]
T. Nagano, M. Yasunaga, K. Goto, et al., Clin. Cancer Res. 15 (2009) 4348-4355.
doi: 10.1158/1078-0432.CCR-08-3334
-
[137]
T.E. Nakajima, M. Yasunaga, Y. Kano, et al., Int. J. Cancer 122 (2008) 2148-2153.
doi: 10.1002/ijc.23381
-
[138]
ClinicalTrials. gov database, (2020). https://www.clinicaltrials.gov/ct2/results?cond=&term=NK012&cntry=&state=&city=&dist=.
-
[139]
S. Sindhwani, A.M. Syed, J. Ngai, et al., Nat. Mater. 19 (2020) 566-575.
doi: 10.1038/s41563-019-0566-2
-
[140]
S.M. Kim, P.H. Faix, J.E. Schnitzer, J. Control. Release 267 (2017) 15-30.
doi: 10.1016/j.jconrel.2017.09.016
-
[141]
R. Daniel, T. Wei, Nat. Commun. 9 (2018) 1410.
doi: 10.1038/s41467-018-03705-y
-
[142]
A. Nel, E. Ruoslahti, H. Meng, ACS Nano 11 (2017) 9567-9569.
doi: 10.1021/acsnano.7b07214
-
[143]
J. Liu, X.X. Ai, H.P. Zhang, et al., J. Biomed. Nanotechnol. 15 (2019) 373-381.
doi: 10.1166/jbn.2019.2693
-
[144]
Y. Qu, B.Y. Chu, K. Shi, et al., J. Biomed. Nanotechnol. 13 (2017) 1598-1618.
doi: 10.1166/jbn.2017.2475
-
[145]
L.M.K. Ma, S. Andrew, ACS Nano 7 (2013) 9518-9525.
doi: 10.1021/nn405674m
-
[146]
E.J. Feldman, J.E. Lancet, J.E. Kolitz, et al., J. Clin. Oncol. 29 (2011) 979-985.
doi: 10.1200/JCO.2010.30.5961
-
[147]
O. Trédan, C.M. Galmarini, P. Krupa, et al., J. Natl. Cancer Inst. 99 (2007) 1441-1454.
doi: 10.1093/jnci/djm135
-
[148]
N. Vasan, J. Baselga, D.M. Hyman, Nature 575 (2019) 299-309.
doi: 10.1038/s41586-019-1730-1
-
[149]
W. Mu, Q. Chu, Y. Liu, N. Zhang, Nano-Micro Lett. 142 (2020).
-
[150]
Z. Yu, J.F. Guo, M.G. Hu, et al., ACS Nano 14 (2020) 4816-4828.
doi: 10.1021/acsnano.0c00708
-
[151]
N. Casares, M.O. Pequignot, A. Tesniere, et al., J. Exp. Med. 202 (2005) 1691-1701.
doi: 10.1084/jem.20050915
-
[152]
J.M. Llovet, J. Zucman-Rossi, E. Pikarsky, et al., Nat. Rev. Dis. Primers 2 (2016) 16018.
doi: 10.1038/nrdp.2016.18
-
[153]
S. Kim, Y. Shi, J.Y. Kim, et al., Expert Opin. Drug Del. 7 (2010) 49-62.
doi: 10.1517/17425240903380446
-
[154]
N.R. Stillman, M. Kovacevic, I. Balaz, et al., NPJ Comput. Mater. 92 (2020), doi:10.1038/s41524-020-00366-8.
doi: 10.1038/s41524-020-00366-8
-
[155]
C. Fornaguera, M. García-Celma, J. Pers. Med. 7 (2017) 1-11.
doi: 10.3390/jpm7010001
-
[156]
D.V. Bazile, J. Drug Deliv. Sci. Tec. 24 (2014) 12-21.
doi: 10.1016/S1773-2247(14)50002-0
-
[157]
M.L. Etheridge, S.A. Campbell, A.G. Erdman, et al., Nanomedicine 9 (2013) 1-14.
doi: 10.1016/j.nano.2012.05.013
-
[158]
J.H. Grossman, J.D. Clogston, AAPS J. 19 (2017) 92-102.
doi: 10.1208/s12248-016-9980-4
-
[159]
S. Tinkle, S.E. McNeil, S. Mühlebach, et al., Ann. NY. Acad. Sci. 1313 (2014) 35-56.
doi: 10.1111/nyas.12403
-
[160]
I.P. Kaur, V. Kakkar, P.K. Deol, et al., J. Control. Release 193 (2014) 51-62.
doi: 10.1016/j.jconrel.2014.06.005
-
[161]
N. Desai, AAPS J. 14 (2012) 282-295.
doi: 10.1208/s12248-012-9339-4
-
[162]
V. Agrahari, P. Hiremath, Nanomedicine 12 (2017) 819-823.
doi: 10.2217/nnm-2017-0039
-
[163]
J.I. Hare, T. Lammers, M.B. Ashford, et al., Adv. Drug Deliv. Rev. 108 (2017) 25-38.
doi: 10.1016/j.addr.2016.04.025